Suppr超能文献

凋亡抑制蛋白与细胞死亡

IAPs and Cell Death.

作者信息

Silke John, Vince James

机构信息

The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.

Department of Medical Biology, University of Melbourne, Melbourne, Australia.

出版信息

Curr Top Microbiol Immunol. 2017;403:95-117. doi: 10.1007/82_2016_507.

Abstract

IAPs were named as inhibitors of apoptosis, programmed cell death, but it has become apparent that they are regulators of other types of cell death too. Because they inhibit cell death in cancer cells there has been an intense interest in developing inhibitors of these proteins to induce or sensitise cancer cells to death. In this article, we will discuss the involvement of IAPs in the apoptosis, necroptosis and pyroptosis programmed cell death paradigms. All these types of cell death are intimately involved with causing or repressing inflammation and it should perhaps therefore come as no surprise that IAPs are also involved in regulating inflammation directly. To come full circle, the IAP antagonist drugs that were developed to sensitise cancer cells to apoptosis have led to some of these insights.

摘要

凋亡抑制蛋白(IAPs)最初被命名为凋亡(程序性细胞死亡)的抑制剂,但现在很明显它们也是其他类型细胞死亡的调节因子。由于它们能抑制癌细胞的死亡,因此人们对开发这些蛋白质的抑制剂以诱导癌细胞死亡或使其对死亡敏感产生了浓厚兴趣。在本文中,我们将讨论IAPs在凋亡、坏死性凋亡和炎性程序性细胞死亡模式中的作用。所有这些类型的细胞死亡都与炎症的引发或抑制密切相关,因此IAPs也直接参与炎症调节或许并不奇怪。兜了一圈,为使癌细胞对凋亡敏感而开发的IAP拮抗剂药物带来了其中一些见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验